远程控制心脏及其他功能
Wolfram-Hubertus Zimmermann1,2,3,4,5,6
1Institute of Pharmacology and Toxicology, University Medical Center Göttingen, Göttingen, Germany.
概括
一个新的可植入装置可以使用闭环系统暂时控制心率. 这种可吸收的技术为心律管理提供了一种新方法.
科学领域:
- 生物医学工程
- 心血管科学
- 可植入的医疗器械
背景情况:
- 心律不整可能造成严重的健康风险.
- 目前用于控制心率的治疗方法有局限性.
- 需要临时的可调节心律管理解决方案.
研究的目的:
- 开发和评估可吸收的闭环传感器驱动器植入物.
- 证明植入物能够暂时控制心率.
主要方法:
- 一个可生物降解的传感器执行系统的设计.
- 用于闭环操作的传感器和执行元件的集成.
- 在体内测试以评估设备的性能和可吸收性.
主要成果:
- 可再吸收装置的成功植入和临时功能.
- 能够感知心脏活动并调节心率.
- 在研究期间,该装置表现出受控的降解.
结论:
- 一个可吸收的闭环传感器驱动器植入物是可行的临时心率控制.
- 这项技术为控制心律提供了潜在的新疗法.
- 需要进一步研究以优化性能和临床适用性.
相关概念视频
Regulation of Heart Rates
2.3K
The regulation of heart rate is a complex process controlled by the autonomic nervous system (ANS), hormonal influences, and intrinsic cardiac mechanisms. The ANS has two main components: the sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS).
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
2.3K
Pulse rhythm
941
Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
941
Conduction System of the Heart
10.0K
Autorhythmicity is a term that refers to the heart's inherent ability to generate electrical signals and instigate muscle contractions. This self-regulating conduction system within the heart consists of two key components: the pacemaker cells and specialized conducting cells.
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
10.0K
Disturbances in Heart Rhythm
1.3K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
1.3K
Pathophysiology of Cardiac Performance
822
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
822
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
528
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
528


